Loading...
•
Dec 31, 2023
NRC Q4 2023 Earnings Report
Announced fourth quarter and calendar year 2023 results, marked by revenue stability and increased diluted earnings per share.
Key Takeaways
NRC Health reported stable revenue of $38 million for the fourth quarter of 2023 compared to the same period in 2022, with diluted earnings per share increasing to $0.36 from $0.27. The company focused on cost control and strategic capital allocation, returning $55 million to stockholders through dividends and stock repurchases during 2023.
Revenue remained stable at $38 million compared to the same quarter last year, as new core sales offset reductions in non-core revenue.
Diluted earnings per share increased to $0.36 from $0.27, driven by new sales, cost control, and reduced share count.
The company returned $55 million to stockholders in 2023 through dividends and stock repurchases.
Capital allocation is expected to focus on growth and innovation initiatives, including facilities renovation and the regular quarterly dividend.
Forward Guidance
The company plans to roll out new Market Experience, PX, CX, and EX products, ramp up sales, IT, and innovative product development resources with a focus on AI enabled solutions, and expand Human Understanding across the experience lifecycle.
Positive Outlook
- Roll out new Market Experience, PX, CX, and EX products.
- Ramp up sales, IT, and innovative product development resources.
- Focus on AI enabled solutions to improve efficiency.
- Expand Human Understanding across the experience lifecycle.
- Increase share across historical and expanded markets.
Challenges Ahead
- No specific negatives were mentioned in the provided text.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...